Detalhe da pesquisa
1.
Risk-adapted bendamustine + rituximab is a tolerable treatment alternative for elderly patients with chronic lymphocytic leukaemia: a regional real-world report on 141 consecutive Swedish patients.
Br J Haematol
; 191(3): 426-432, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32779190
2.
Phase I-II study of lenalidomide and alemtuzumab in refractory chronic lymphocytic leukemia (CLL): effects on T cells and immune checkpoints.
Cancer Immunol Immunother
; 66(1): 91-102, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27815572
3.
Real-world results of ibrutinib in patients with relapsed or refractory chronic lymphocytic leukemia: data from 95 consecutive patients treated in a compassionate use program. A study from the Swedish Chronic Lymphocytic Leukemia Group.
Haematologica
; 101(12): 1573-1580, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27198718
4.
Long-term real-world results of ibrutinib therapy in patients with relapsed or refractory chronic lymphocytic leukemia: 30-month follow up of the Swedish compassionate use cohort.
Haematologica
; 104(5): e208-e210, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30514799
5.
Dual targeting of Bruton tyrosine kinase and CD52 induces minimal residual disease-negativity in the bone marrow of poor-prognosis chronic lymphocytic leukaemia patients but is associated with opportunistic infections - Results from a phase I study.
Br J Haematol
; 182(4): 590-594, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28677818
6.
Dual targeting fixed duration frontline monoclonal antibody therapy for chronic lymphocytic leukemia: A phase 2 study.
Leuk Res
; 122: 106945, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36115087
7.
A real-world study of first-line therapy in 280 consecutive Swedish patients ≥80 years with newly diagnosed diffuse large B-cell lymphoma: very elderly (≥85 years) do well on curative intended therapy.
Leuk Lymphoma
; 61(9): 2136-2144, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32449636
8.
Outcomes of second-line treatment in chronic lymphocytic leukemia - a population-based study from a well defined geographical region between 2003 and 2013.
Leuk Lymphoma
; 58(5): 1219-1223, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27894205